Clinical significance of putative cancer stem cell marker CD44 in different histological subtypes of lung cancer

Abstract

CD44 could be a valuable tool for the study of lung CSCs and provide a novel therapeutic target for treatment of the patients with lung cancer in combination with conventional therapy.